Empower Clinics Inc.
EPWCF · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 3.38 | -0.59 | -0.02 | 0.02 |
| FCF Yield | -0.48% | -7.90% | -4.72% | -82.79% |
| EV / EBITDA | -5.20 | -2.68 | -2.30 | -1.56 |
| Quality | ||||
| ROIC | 403.22% | 346.38% | -85.17% | 1,297.44% |
| Gross Margin | 42.21% | 30.88% | 62.82% | 59.30% |
| Cash Conversion Ratio | 1.47 | 0.13 | 0.10 | 0.53 |
| Growth | ||||
| Revenue 3-Year CAGR | 13.26% | 29.07% | 43.28% | 9.19% |
| Free Cash Flow Growth | 99.93% | -228.83% | 16.90% | 22.44% |
| Safety | ||||
| Net Debt / EBITDA | -4.39 | -0.12 | 0.08 | -0.80 |
| Interest Coverage | -3.20 | -29.35 | -6.54 | -9.67 |
| Efficiency | ||||
| Inventory Turnover | 4.96 | 14.73 | 67.53 | 37.82 |
| Cash Conversion Cycle | -182.38 | -176.66 | -551.66 | -576.67 |